This is the letter i received on the study.
The study team will use ultrasound, as originally used by Dr. Zamboni, and magnetic resonance imaging of the veins (MR venography). This study will help determine whether there are significant differences in the venous drainage of people with MS compared to people without MS. This will determine if trials of therapy should be directed at the veins.
We have received funding to enroll 120 MS patients. This will include approximately 65 people with relapsing-remitting MS, 20 people with secondary progressive MS, 10 with primary progressive MS, 10 with neuromyelitis optica (Devic’s Disease), and 15 pediatric MS patients. In addition, we will enroll 60 healthy participants. All MS patients will be recruited from the Calgary MS Clinic. As we have over 5,000 patients in our clinic, most interested participants will not be able to participate in this study.
Our team is eager to get started on this exciting project. However, as per any clinical research study, there are a number of administrative items that need to be completed in order to begin. First of all, the funding for the study is expected in July 2010. Secondly, we are in the process of obtaining ethics review board approval, organizing some administrative infrastructure requirements, and completing our study participation protocols. We thank you for your patience while all of the necessary components of the study are put into place before we contact potential study patients. We cannot provide any additional information until we have received approval from the University of Calgary Research Ethics Committee.